Investors Nu-Med Plus Stock Chart Nu-Med Plus Inc. Latest News July 30, 2020 Patent Issued for Single-Use or Short-Term Nitric Oxide Delivery Device April 07, 2020 What is Nitric Oxide? How the gas that gave us Viagra could help treat Coronavirus patients April 06, 2020 Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19 January 07, 2020 Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage December 04, 2019 Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City June 18, 2019 Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners June 18, 2019 Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval February 08, 2019 Miniaturized Inhaled Nitric Oxide Delivery Units for Use in a Doctor’s Office February 05, 2019 Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings January 03, 2019 Nu-Med Plus’ Blood Transfusion Technology Featured in Deseret News November 14, 2018 Nu-Med Plus, Inc. Advances Blood and Plasma Transfusion Technology with New Patent November 02, 2018 Letter From Our President September 26, 2018 Nu-Med Plus, Inc. announces Vice President of Medical Marketing discusses the exciting future of Nitric Oxide September 20, 2018 Medical Use of Nitric Oxide Expands as Costs Come Down September 12, 2018 Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study August 31, 2018 As Nitric Oxide Comes Off Patent, Lower-Cost Options for Life Saving Drug Becoming Possible August 29, 2018 Nu-Med Plus, Inc. Strategically Positioned After Monopoly- Ending Patent Ruling Opens Nitric Oxide Market August 29, 2018 Medical Device Firm Anticipates Benefit from Patent Ruling July 31, 2018 Nu-Med Plus, Inc. Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval June 26, 2018 Nu-Med Plus, Inc. Selects s2s Public Relations firm as its Strategic Partner June 12, 2018 Nu-Med Plus, Inc. Engages Millennium Biosciences for Quality and Regulatory Consulting Services June 05, 2018 Nu-Med Plus Inc. applies for Innovative Patent on Reactive Tube Coating April 28, 2018 Nu-Med Plus Shareholders Re-Elect All 5 Directors at 2018 Shareholder Meeting February 13, 2018 Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer January 30, 2018 Nu-Med Plus, Inc. announces trading on OTCQB Marketplace October 10, 2017 Franklin Innovation joins Nu-Med Plus development team for FDA submission of Nitric Oxide Hospital Medical Device October 03, 2017 Nu-Med Plus, Inc. Selects Salient Technologies, Inc. for Go to Market Design of Nitric Oxide Medical Device for FDA Submission June 27, 2017 Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology April 05, 2017 Nu-Med Plus Selects Houlihan Advisors to Valuate Company February 08, 2017 Nu-Med Plus, Inc. Signs Significant Investment Agreement December 13, 2016 Nu-Med Plus, Inc. Selects Dr. Michael Johnson M.D. as their Strategic Regulatory Adviser August 02, 2016 Nu-Med Plus Upgrades Nitric Oxide Delivery System in Preparation for FDA Filing View More Explore More AboutNu-Med Plus Crunchbase Join the Nu-MedPlus Solution Connect With Us
April 07, 2020 What is Nitric Oxide? How the gas that gave us Viagra could help treat Coronavirus patients
April 06, 2020 Nu-Med Plus Closely Monitoring Outcomes on Two New Human Clinical Trials Using Inhaled Nitric Oxide in Treatment of COVID-19
January 07, 2020 Patent filed for Nitric Oxide Delivery Device that is comparable to inhalers for single or short-term usage
December 04, 2019 Nu-Med Plus Presents at the 147th National Investment Banking Association Conference on November 12-13, 2019 in New York City
June 18, 2019 Nu-Med Plus Reports Spike in International Interest from Physicians, Distributors, and Potential Strategic Partners
June 18, 2019 Nu-Med Plus, Inc. Approaches Milestone FDA Application for New Nitric Oxide Medical Device Approval
February 05, 2019 Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
September 26, 2018 Nu-Med Plus, Inc. announces Vice President of Medical Marketing discusses the exciting future of Nitric Oxide
September 12, 2018 Nu-Med Plus, Inc. Announces Prominent Research Lab to Utilize its New Advanced Nitric Oxide Delivery Product for Study
August 31, 2018 As Nitric Oxide Comes Off Patent, Lower-Cost Options for Life Saving Drug Becoming Possible
August 29, 2018 Nu-Med Plus, Inc. Strategically Positioned After Monopoly- Ending Patent Ruling Opens Nitric Oxide Market
July 31, 2018 Nu-Med Plus, Inc. Approaches Landmark Certification to Speed New Nitric Oxide Medical Device Approval
June 12, 2018 Nu-Med Plus, Inc. Engages Millennium Biosciences for Quality and Regulatory Consulting Services
February 13, 2018 Nu-Med Plus Announces Keith L. Merrell as their full-time Chief Financial Officer and Secretary/Treasurer
October 10, 2017 Franklin Innovation joins Nu-Med Plus development team for FDA submission of Nitric Oxide Hospital Medical Device
October 03, 2017 Nu-Med Plus, Inc. Selects Salient Technologies, Inc. for Go to Market Design of Nitric Oxide Medical Device for FDA Submission
June 27, 2017 Nu-Med Plus Inc. Announces Patent Approval Notification For Low Cost Nitric Oxide Technology
December 13, 2016 Nu-Med Plus, Inc. Selects Dr. Michael Johnson M.D. as their Strategic Regulatory Adviser